Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
5.81
+0.83 (16.67%)
At close: Apr 8, 2026, 4:00 PM EDT
5.84
+0.03 (0.52%)
After-hours: Apr 8, 2026, 6:16 PM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $24.19 million as of April 8, 2026. Its market cap has decreased by -87.88% in one year.
Market Cap
24.19M
Enterprise Value
31.14M
1-Year Change
-87.88%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $24.19M, a decrease of -94.58%. That is a compound annual growth rate of -49.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 20.74M | -68.48% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 25.77M |
| Exicure | 25.69M |
| NeuroSense Therapeutics | 25.49M |
| Neuphoria Therapeutics | 25.34M |
| Serina Therapeutics | 24.87M |
| Marker Therapeutics | 24.34M |
| Barinthus Biotherapeutics | 24.07M |
| Lexaria Bioscience | 23.77M |